Q. America is in the grip of a terrible epidemic: addiction to pain-relieving prescription medicines. What responsibility do you think the manufacturers, distributors and prescribers of these drugs have in this crisis?
A. I think they bear plenty of responsibility, which some of them—and their professional associations—have been reluctant to accept.
Ultimately, individuals are responsible for their own health and what they put into their bodies. But when pain is strong and/or chronic, there is a natural tendency for patients to ask for whatever will ease it, and with this comes the risk of addiction to opioids.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
That’s why physicians and dentists need mandatory pain-management training, starting in medical and dental schools and continuing thereafter. They should first prescribe the mildest, nonaddictive, over-the-counter pain remedies. If they step their patients up to more-powerful prescription drugs, they should be required to limit the initial supply, counsel their patients and monitor them carefully for early signs of addiction.
States must maintain well-funded, real-time prescription-drug monitoring programs so that prescribers and pharmacists can spot patients who get prescriptions from multiple physicians, dentists and pharmacies, as well as see patterns of over-prescribing of painkillers by medical professionals—either by negligence or for illegal resale purposes (“pill mills”).
Manufacturers of prescription painkillers have to recognize that some portion of the soaring sales and profits they have enjoyed are coming from both overuse by legitimate patients and illegal black markets. Some manufacturers are belatedly endorsing mandatory physician training in pain management and even physician licensing by the federal Drug Enforcement Administration for prescribing opioids.
Sadly, tougher training and prescribing standards for American health care professionals are not enough. The addiction epidemic is now being fed by supply chains that go far beyond U.S. drugmakers and medical professionals. An internet mail-order market is flourishing, and foreign supplies of generic opioids are flooding into our country. China has agreed to ban the export of more than 100 drugs, but new sources are constantly arising. This epidemic must be fought on many fronts.
-
Top Tech Gifts to Grab at Walmart Before ChristmasBig savings on Apple, Bose, HP, Vizio and more while there's still time to shop.
-
AI Appliances Aren’t Exciting Buyers…YetThe Kiplinger Letter Artificial intelligence is being embedded into all sorts of appliances. Now sellers need to get customers to care about AI-powered laundry.
-
Ask the Editor: IRAs, 401(k)s and RMDsAsk the Editor In this week's Ask the Editor Q&A, Joy Taylor answers questions on IRAs, 401(k)s and required minimum distributions
-
Should All Student Debt Be Forgiven?student loans My favorite reform would be making the repayment of all student loans proportional to the borrower’s future earnings.
-
Should Lenders Mail Unsolicited Checks to Potential Borrowers?credit & debt When it comes to preying on weak credit risks, it looks like Wall Street is at it again.
-
Do Adult Children Have an Obligation to Support Needy Parents?savings Even if some siblings can afford to help more than others, no one should shirk the obligation to assist in some way -- financial or otherwise.
-
Should Nondisclosure Agreements Be Banned in Sexual Harassment Settlements?Business Costs & Regulation Knight Kiplinger offers his advice on how companies can improve their handling of harassment problems.
-
How Can the Approval Process for New Drugs Be Speeded Up?investing There are many reform proposals, including some from free-market think tanks.
-
Are Incentives to Lure New Businesses Fair to Current Employers?Business Costs & Regulation Job growth and spending at an existing firm should be worth just as much in incentives as new jobs and capital investment brought in from outside.
-
Should Ethics Determine Who You Do Business With?Smart Buying Consumers seeking to do business only with ethical companies should ask these questions.
-
Should Colleges Use Collection Agencies for Overdue Student Bills?college Colleges have many potent options for getting students to square their accounts.
